LeJeune Puetz Investment Counsel’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-12,386
Closed -$283K 191
2022
Q1
$283K Sell
12,386
-364
-3% -$8.9K 0.1% 135
2021
Q4
$352K Hold
12,750
0.12% 126
2021
Q3
$355K Hold
12,750
0.13% 126
2021
Q2
$374K Hold
12,750
0.14% 122
2021
Q1
$405K Hold
12,750
0.16% 119
2020
Q4
$265K Hold
12,750
0.11% 129
2020
Q3
$198K Hold
12,750
0.1% 137
2020
Q2
$233K Hold
12,750
0.12% 125
2020
Q1
$198K Hold
12,750
0.12% 128
2019
Q4
$381K Hold
12,750
0.18% 112
2019
Q3
$279K Hold
12,750
0.14% 124
2019
Q2
$322K Hold
12,750
0.17% 115
2019
Q1
$315K Buy
12,750
+2,250
+21% +$53.7K 0.17% 115
2018
Q4
$194K Hold
10,500
0.12% 128
2018
Q3
$270K Hold
10,500
0.16% 121
2018
Q2
$244K Hold
10,500
0.15% 121
2018
Q1
$167K Hold
10,500
0.1% 128
2017
Q4
$218K Hold
10,500
0.13% 117
2017
Q3
$150K Sell
10,500
-2,500
-19% -$37.8K 0.1% 132
2017
Q2
$225K Hold
13,000
0.15% 116
2017
Q1
$143K Buy
13,000
+4,500
+53% +$61.9K 0.1% 133
2016
Q4
$123K Buy
+8,500
New +$156K 0.09% 134

Other funds holding BHC

LeJeune Puetz Investment Counsel's BHC Position: Q2 2022 in Review

LeJeune Puetz Investment Counsel sold out of Bausch Health (BHC) in Q2 2022, closing a stake of 12,386 shares — an estimated $283K sold.

LeJeune Puetz Investment Counsel first reported a position in BHC in Q4 2016 and held it in 22 quarters. The position peaked at $405K in Q1 2021. 327 funds tracked by Wall St. Rank hold BHC as of Q2 2022.

  • LeJeune Puetz Investment Counsel reported no remaining Bausch Health position as of Q2 2022 after selling out during the quarter.
  • LeJeune Puetz Investment Counsel sold 12,386 Bausch Health shares in Q2 2022, an estimated $283K.
  • LeJeune Puetz Investment Counsel first reported a position in Bausch Health in Q4 2016 and held it in 22 quarters.
  • LeJeune Puetz Investment Counsel's Bausch Health position peaked at $405K in Q1 2021.
  • 327 funds tracked by Wall St. Rank held Bausch Health as of Q2 2022.

Based on LeJeune Puetz Investment Counsel's 13F filing for Q2 2022, filed 21 Jul 2022.